182 related articles for article (PubMed ID: 14647463)
1. Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression.
Suzuki M; Yamada T; Kihara-Negishi F; Sakurai T; Oikawa T
Oncogene; 2003 Nov; 22(54):8688-98. PubMed ID: 14647463
[TBL] [Abstract][Full Text] [Related]
2. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression.
Kihara-Negishi F; Yamamoto H; Suzuki M; Yamada T; Sakurai T; Tamura T; Oikawa T
Oncogene; 2001 Sep; 20(42):6039-47. PubMed ID: 11593411
[TBL] [Abstract][Full Text] [Related]
3. Impaired repressor activity and biological functions of PU.1 in MEL cells induced by mutations in the acetylation motifs within the ETS domain.
Kihara-Negishi F; Suzuki M; Yamada T; Sakurai T; Oikawa T
Biochem Biophys Res Commun; 2005 Sep; 335(2):477-84. PubMed ID: 16098914
[TBL] [Abstract][Full Text] [Related]
4. Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b.
Suzuki M; Yamada T; Kihara-Negishi F; Sakurai T; Hara E; Tenen DG; Hozumi N; Oikawa T
Oncogene; 2006 Apr; 25(17):2477-88. PubMed ID: 16331260
[TBL] [Abstract][Full Text] [Related]
5. Interaction between the homeodomain protein HOXC13 and ETS family transcription factor PU.1 and its implication in the differentiation of murine erythroleukemia cells.
Yamada T; Shimizu T; Suzuki M; Kihara-Negishi F; Nanashima N; Sakurai T; Fan Y; Akita M; Oikawa T; Tsuchida S
Exp Cell Res; 2008 Feb; 314(4):847-58. PubMed ID: 18076876
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
[TBL] [Abstract][Full Text] [Related]
7. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing.
Harikrishnan KN; Chow MZ; Baker EK; Pal S; Bassal S; Brasacchio D; Wang L; Craig JM; Jones PL; Sif S; El-Osta A
Nat Genet; 2005 Mar; 37(3):254-64. PubMed ID: 15696166
[TBL] [Abstract][Full Text] [Related]
8. Myeloid transforming protein Evi1 interacts with methyl-CpG binding domain protein 3 and inhibits in vitro histone deacetylation by Mbd3/Mi-2/NuRD.
Spensberger D; Vermeulen M; Le Guezennec X; Beekman R; van Hoven A; Bindels E; Stunnenberg H; Delwel R
Biochemistry; 2008 Jun; 47(24):6418-26. PubMed ID: 18500823
[TBL] [Abstract][Full Text] [Related]
9. Prevention of PU.1-induced growth inhibition and apoptosis but not differentiation block in murine erythroleukemia cells by overexpression of CBP.
Manabe N; Yamamoto H; Yamada T; Kihara-Negishi F; Hashimoto Y; Mochizuki M; Oikawa T
Int J Oncol; 2003 Jun; 22(6):1345-50. PubMed ID: 12739003
[TBL] [Abstract][Full Text] [Related]
10. Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells.
Waga K; Nakamura Y; Maki K; Arai H; Yamagata T; Sasaki K; Kurokawa M; Hirai H; Mitani K
Oncogene; 2003 Jan; 22(1):59-68. PubMed ID: 12527908
[TBL] [Abstract][Full Text] [Related]
11. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
Wu Y; Zhang X; Salmon M; Zehner ZE
Genes Cells; 2007 Aug; 12(8):905-18. PubMed ID: 17663720
[TBL] [Abstract][Full Text] [Related]
12. Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism.
McGhee L; Bryan J; Elliott L; Grimes HL; Kazanjian A; Davis JN; Meyers S
J Cell Biochem; 2003 Aug; 89(5):1005-18. PubMed ID: 12874834
[TBL] [Abstract][Full Text] [Related]
13. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
[TBL] [Abstract][Full Text] [Related]
14. In vivo repression of an erythroid-specific gene by distinct corepressor complexes.
Rietveld LE; Caldenhoven E; Stunnenberg HG
EMBO J; 2002 Mar; 21(6):1389-97. PubMed ID: 11889044
[TBL] [Abstract][Full Text] [Related]
15. Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer.
Müller-Tidow C; Kügler K; Diederichs S; Klümpen S; Möller M; Vogt U; Metzger R; Schneider PM; Berdel WE; Serve H
Br J Cancer; 2001 Oct; 85(8):1168-74. PubMed ID: 11710831
[TBL] [Abstract][Full Text] [Related]
16. Purification of the MeCP2/histone deacetylase complex from Xenopus laevis.
Jones PL; Wade PA; Wolffe AP
Methods Mol Biol; 2001; 181():297-307. PubMed ID: 12843459
[TBL] [Abstract][Full Text] [Related]
17. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
18. FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain.
Maurer P; T'Sas F; Coutte L; Callens N; Brenner C; Van Lint C; de Launoit Y; Baert JL
Oncogene; 2003 May; 22(21):3319-29. PubMed ID: 12761502
[TBL] [Abstract][Full Text] [Related]
19. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F; Friese O; Pantel K; Schwarzenbach H
Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional repression mediated by the KRAB domain of the human C2H2 zinc finger protein Kox1/ZNF10 does not require histone deacetylation.
Lorenz P; Koczan D; Thiesen HJ
Biol Chem; 2001 Apr; 382(4):637-44. PubMed ID: 11405226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
